30 minutes: 20 minutes at 250 degrees, and 10 minutes venting time.
Namenda is the brand name of the prescription drug memantine, which is used to treat symptoms of Alzheimer's disease and severe dementia. The medicine works by decreasing abnormal activity in the brain. It's in a class of drugs known as NMDA (N-methyl-D-aspartate) receptor antagonists. Namenda is manufactured by Forest Laboratories, Inc., and was approved by the Food and Drug Administration (FDA) in 2010.
Each of the AD trials were approximately 6 months in duration, and the memantine treatment group had a greater completion rate for all three trials. Memantine was tested as a monotherapy for AD in the MRZ9605 and MEM-MD-01 trials.